Selective loss of chondroitin 6-sulphate from basement membrane during progression from actinic keratosis to squamous cell carcinoma.
Kazama
T
T
Department of Dermatology, Niigata University School of Medicine, Japan.
Fujiwara
K
K
Ito
M
M
D000911:Antibodies, Monoclonal; D001485:Basement Membrane / Q000378:metabolism; D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000473:pathology; D002809:Chondroitin Sulfates / Q000276:immunology / Q000378:metabolism*; D002810:Chondroitinases and Chondroitin Lyases / Q000276:immunology; D003094:Collagen / Q000276:immunology; D019812:Heparan Sulfate Proteoglycans; D006497:Heparan Sulfate / Q000276:immunology; D006801:Humans; D007150:Immunohistochemistry; D007642:Keratosis / Q000378:metabolism* / Q000473:pathology; D007797:Laminin / Q000276:immunology; D011509:Proteoglycans / Q000276:immunology; D012878:Skin Neoplasms / Q000378:metabolism* / Q000473:pathology
D000911:Antibodies, Monoclonal; D002809:Chondroitin Sulfates; D002810:Chondroitinases and Chondroitin Lyases; D003094:Collagen; D019812:Heparan Sulfate Proteoglycans; D006497:Heparan Sulfate; D007797:Laminin; D011509:Proteoglycans